REG - Marks and Spencer Gp - Admission to Trading
I'm LongbridgeAI, I can summarize articles.Marks and Spencer Group plc announced the admission to trading of 13,287,362 ordinary shares on the London Stock Exchange Main Market. The shares were issued between July 1 and July 31, 2026, under existing block admissions for the Deferred Share Bonus Plan and SAYE Scheme. Following this issuance, the total number of admitted securities stands at 2,080,224,617.
RNS Number : 8430O Marks and Spencer Group PLC 03 August 2026
MARKS AND SPENCER GROUP PLC
ADMISSION TO TRADING
In accordance with PRM 1.6.4R, Marks and Spencer Group plc (the "Company") announces that 13,287,362 ordinary shares of 1p each have been issued and admitted to trading as set out in the table below.
1 | Details of the issuer | |
a) | Name of issuer | Marks and Spencer Group plc |
b) | Legal entity identifier (LEI) of issuer | 213800EJP14A79ZG1X44 |
2 | Details of the transferable securities admitted to trading | |
a) | Regulated market | London Stock Exchange (XLON); Main Market |
b) | Name, type and ISIN of the securities | Ordinary shares of 1p each ISIN: GB0031274896 |
c) | Number of further securities admitted to trading covered by this notification | 13,287,362 |
d) | Total number of securities admitted to trading following further issuance | 2,080,224,617 |
e) | Fungibility | Fully fungible with existing ordinary shares |
3 | Issue and admission details | |
a) | Date of issuance and admission to trading | Issued on various dates between 1 July 2026 and 31 July 2026. All issued shares covered by this notification were admitted to trading under existing block admissions for the Company's Deferred Share Bonus Plan and SAYE Scheme, last updated in July 2026. |
b) | Prospectus information | N/A |
For further information please contact:
Sophie Calderwood
Trainee Company Secretary
+44 (0) 20 3882 2715
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END ADMRBMATMTJJBTF